| [1] |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants [J]. Chin Med J (Engl), 2022, 135(5): 584-590.
|
| [2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [3] |
Maomao C, He L, Dianqin S, et al. Current cancer burden in China: epidemiology, etiology, and prevention [J]. Cancer Biol Med, 2022, 19(8): 1121-1138.
|
| [4] |
Peng Y, Croce CM. The role of MicroRNAs in human cancer [J]. Signal Transduct Target Ther, 2016, 1: 15 004.
|
| [5] |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004, 116(2): 281-297.
|
| [6] |
Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact [J]. J Clin Oncol, 2009, 27(34): 5848-5856.
|
| [7] |
Mishan MA, Tabari MAK, Parnian J, et al. Functional mechanisms of miR-192 family in cancer [J]. Genes Chromosomes Cancer, 2020, 59(12): 722-735
|
| [8] |
Khella HW, Bakhet M, Allo G, et al. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma [J]. Carcinogenesis, 2013, 34(10): 2231-2239.
|
| [9] |
Kabekkodu SP, Shukla V, Varghese VK, et al. Clustered miRNAs and their role in biological functions and diseases [J]. Biol Rev Camb Philos Soc, 2018, 93(4): 1955-1986.
|
| [10] |
Wang J, Haubrock M, Cao KM, et al. Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network [J]. BMC Syst Biol, 2011, 5: 199.
|
| [11] |
Sun Y, Koo S, White N, et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs [J]. Nucleic Acids Res, 2004, 32(22): e188.
|
| [12] |
Komatsu S, Kitai H, Suzuki HI. Network regulation of microRNA biogenesis and target interaction [J]. Cells, 2023, 12(2)：306.
|
| [13] |
Hino K, Tsuchiya K, Fukao T, et al. Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation [J]. RNA, 2008, 14(7): 1433-1442.
|
| [14] |
Jenkins RH, Martin J, Phillips AO, et al. Transforming growth factor β1 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding [J]. Biochem J, 2012, 443(2): 407-416.
|
| [15] |
Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers [J]. Nature, 2005, 435(7043): 834-838.
|
| [16] |
Lian J, Jing Y, Dong Q, et al. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma [J]. Oncotarget, 2016, 7(3): 2672-2683.
|
| [17] |
Qiu L, Wang T, Ge Q, et al. Circular RNA signature in hepatocellular carcinoma [J]. J Cancer, 2019, 10(15): 3361-3372.
|
| [18] |
Gu Y, Wei X, Sun Y, et al. miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features [J]. Cancer Res, 2019, 79(5): 941-953.
|
| [19] |
Moratin J, Hartmann S, Brands RC, et al. MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma [J]. J Craniomaxillofac Surg, 2019, 47(3): 523-529.
|
| [20] |
Wang Y, Yang L, Chen T, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis [J]. Mol Cancer, 2019, 18(1): 28.
|
| [21] |
Meng X, Li Z, Zhou S, et al. miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5 [J]. Thorac Cancer, 2019, 10(5): 1051-1059.
|
| [22] |
Wang C, Li X, Zhang L, et al. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer [J]. Int Immunopharmacol, 2021, 97: 107 822.
|
| [23] |
Zhao J, Wang Y, Wang Y, et al. miR-194-3p represses the docetaxel resistance in colon cancer by targeting KLK10 [J]. Pathol Res Pract, 2022, 236: 153 962.
|
| [24] |
Cai X, Peng D, Wei H, et al. miR-215 suppresses proliferation and migration of non-small cell lung cancer cells [J]. Oncol Lett, 2017, 13(4): 2349-2353.
|
| [25] |
Han J, Zhang M, Nie C, et al. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1 [J]. Cell Death Dis, 2019, 10(3): 195.
|
| [26] |
Song Z, Bai J, Jiang R, et al. MicroRNA-215-5p promotes proliferation, invasion, and inhibits apoptosis in liposarcoma cells by targeting MDM2 [J]. Cancer Med, 2023, 12(12): 13 455-13 470.
|
| [27] |
Gao X, Cai Y, An R. miR-215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer [J]. Int J Mol Med, 2018, 42(3): 1229-1236.
|
| [28] |
Zang Y, Wang T, Pan J, et al. miR-215 promotes cell migration and invasion of gastric cancer cell lines by targeting FOXO1 [J]. Neoplasma, 2017, 64(4): 579-587.
|
| [29] |
Moore R, Ooi HK, Kang T, et al. MiR-192-mediated positive feedback loop controls the robustness of stress-induced p53 oscillations in breast cancer cells [J]. PLoS Comput Biol, 2015, 11(12): e1004653.
|
| [30] |
Braun CJ, Zhang X, Savelyeva I, et al. p53-responsive micrornas 192 and 215 are capable of inducing cell cycle arrest [J]. Cancer Res, 2008, 68(24): 10 094-10 104.
|
| [31] |
Chen P, Feng Y, Zhang H, et al. MicroRNA-192 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting caveolin 1 [J]. Oncol Rep, 2019, 42(5): 1667-1676.
|
| [32] |
Vajen B, Greiwe L, Schäffer V, et al. MicroRNA-192-5p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase activating protein 19 [J]. Genes Chromosomes Cancer, 2021, 60(11): 733-742.
|
| [33] |
Zhang Y, He Y, Lu LL, et al. miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A [J]. Kaohsiung J Med Sci, 2019, 35(1): 17-23.
|
| [34] |
Kim YS, Park SJ, Lee YS, et al. miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer [J]. Oncotarget, 2016, 7(27): 42 261-42 273.
|
| [35] |
Iizuka D, Imaoka T, Nishimura M, et al. Aberrant microRNA expression in radiation-induced rat mammary cancer: the potential role of miR-194 overexpression in cancer cell proliferation [J]. Radiat Res, 2013, 179(2): 151-159.
|
| [36] |
Chen Y, Wei H, Liu Y, et al. Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7 [J]. Oncol Lett, 2018, 15(4): 4439-4444.
|
| [37] |
Yang F, Xiao Z, Zhang S. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway [J]. Int J Mol Med, 2018, 42(6): 3355-3363.
|
| [38] |
Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy [J]. Nat Rev Cancer, 2012, 12(4): 252-264.
|
| [39] |
Hamed MM, Handoussa H, Hussein NH, et al. Oleuropin controls miR-194/XIST/PD-L1 loop in triple negative breast cancer: New role of nutri-epigenetics in immune-oncology [J]. Life Sci, 2021, 277: 119 353.
|
| [40] |
Sereno M, Haskó J, Molnár K, et al. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization [J]. Mol Oncol, 2020, 14(3): 520-538.
|
| [41] |
Yen YT, Yang JC, Chang JB, et al. Down-regulation of miR-194-5p for predicting metastasis in breast cancer cells [J]. Int J Mol Sci, 2021, 23(1): 325.
|
| [42] |
Le XF, Almeida MI, Mao W, et al. Modulation of microRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer [J]. PLoS One, 2012, 7(7): e41170.
|
| [43] |
Javadian M, Shekari N, Soltani-Zangbar MS, et al. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions [J]. J Cell Biochem, 2020, 121(3): 2416-2427.
|
| [44] |
Elieh Ali Komi D, Shekari N, Soofian-Kordkandi P, et al. Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line [J]. Clin Nutr ESPEN, 2021, 46: 477-483.
|
| [45] |
Wang M, Liao J, Tan C, et al. Integrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B [J]. J Cell Mol Med, 2021, 25(7): 3327-3338.
|
| [46] |
Gao JB, Zhu MN, Zhu XL. miRNA-215-5p suppresses the aggressiveness of breast cancer cells by targeting Sox9 [J]. FEBS Open Bio, 2019, 9(11): 1957-1967.
|
| [47] |
Yao J, Zhang P, Li J, et al. MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1 [J]. Oncol Lett, 2017, 14(1): 1097-1104.
|
| [48] |
Leblanc N, Harquail J, Crapoulet N, et al. Pax-5 inhibits breast cancer proliferation through miR-215 up-regulation [J]. Anticancer Res, 2018, 38(9): 5013-5026.
|
| [49] |
Wu CL, Xu LL, Peng J, et al. Al-MPS obstructs EMT in breast cancer by inhibiting lipid metabolism via miR-215-5p/SREBP1 [J]. Endocrinology, 2022, 163(5): bqac040.
|
| [50] |
Kong X, Duan Y, Sang Y, et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215 [J]. J Cell Physiol, 2019, 234(6): 9105-9117.
|
| [51] |
Wu XP, Xu ZQ, Xie WM, et al. Long non-coding RNA GAS6-AS1 enhances breast cancer cell aggressiveness by functioning as a competing endogenous RNA of microRNA-215-5p to enhance SOX9 expression [J]. Exp Ther Med, 2022, 23(1): 109.
|
| [52] |
Tripathi SK, Mathaiyan J, Kayal S, et al. Identification of differentially expressed mirna by next generation sequencing in locally advanced breast cancer patients of south Indian origin [J]. Asian Pac J Cancer Prev, 2022, 23(7): 2255-2261.
|
| [53] |
Tavakolian S, Goudarzi H, Torfi F, et al. Evaluation of microRNA-9 and -192 expression levels as biomarkers in patients suffering from breast cancer [J]. Biomed Rep, 2020, 12(1): 30-34.
|
| [54] |
Wu Q, Lu Z, Li H, et al. Next-generation sequencing of microRNAs for breast cancer detection [J]. J Biomed Biotechnol, 2011, 2011: 597 145.
|
| [55] |
Fang R, Zhu Y, Hu L, et al. Plasma microRNA pair panels as novel biomarkers for detection of early stage breast cancer [J]. Front Physiol, 2018, 9: 1879.
|
| [56] |
Canatan D, Sönmez Y, Yilmaz Ö，et al. MicroRNAs as biomarkers for breast cancer [J]. Acta Biomed, 2021, 92(2): e2021028.
|
| [57] |
Zhou SW, Su BB, Zhou Y, et al. Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients [J]. Med Oncol, 2014, 31(11): 259.
|
| [58] |
Li M, Zou X, Xia T, et al. A five-miRNA panel in plasma was identified for breast cancer diagnosis [J]. Cancer Med, 2019, 8(16): 7006-7017.
|
| [59] |
Erceylan ÖF, Savaş A, Göv E. Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer [J]. Turk J Biol, 2021, 45(2): 127-137.
|
| [60] |
Madhavan D, Peng C, Wallwiener M, et al. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis [J]. Carcinogenesis, 2016, 37(5): 461-470.
|
| [61] |
van Schooneveld E, Wouters MC, Van der Auwera I, et al. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers [J]. Breast Cancer Res, 2012, 14(1): R34.
|
| [62] |
Pizzamiglio S, Cosentino G, Ciniselli CM, et al. What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study [J]. Cancer Med, 2022, 11(2): 332-339.
|
| [63] |
Hironaka-Mitsuhashi A, Matsuzaki J, Takahashi RU, et al. A tissue microRNA signature that predicts the prognosis of breast cancer in young women [J]. PLoS One, 2017, 12(11): e0187638.
|
| [64] |
He Y, Deng F, Zhao S, et al. Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1 [J]. Epigenomics, 2019, 11(9): 1021-1036.
|
| [65] |
Figueira I, Godinho-Pereira J, Galego S, et al. MicroRNAs and extracellular vesicles as distinctive biomarkers of precocious and advanced stages of breast cancer brain metastases development [J]. Int J Mol Sci, 2021, 22(10): 5214.
|
| [66] |
Di Cosimo S, Ciniselli CM, Pizzamiglio S, et al. End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: an exploratory analysis from NeoALTTO [J]. Front Oncol, 2022, 12: 1 028 825.
|